Literature DB >> 15047104

Bioactivation and resistance to mitomycin C.

Helen A Seow1, Philip G Penketh, Raymond P Baumann, Alan C Sartorelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15047104     DOI： 10.1016/S0076-6879(04)82012-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

1.  Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity.

Authors:  Yun Wang; Joshua P Gray; Vladimir Mishin; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Mol Cancer Ther       Date:  2010-05-25       Impact factor: 6.261

2.  Xanthoria elegans (Link) (lichen) extract counteracts DNA damage and oxidative stress of mitomycin C in human lymphocytes.

Authors:  Hasan Turkez; Elanur Aydin; Ali Aslan
Journal:  Cytotechnology       Date:  2012-03-24       Impact factor: 2.058

3.  NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer.

Authors:  Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

4.  CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy.

Authors:  Steve H Thorne; Yoram Barak; Wenchuan Liang; Michael H Bachmann; Jianghong Rao; Christopher H Contag; A Matin
Journal:  Mol Cancer Ther       Date:  2009-02-03       Impact factor: 6.261

5.  Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.

Authors:  D Jamieson; A T Y Tung; R J Knox; A V Boddy
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

Review 6.  Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity.

Authors:  Sylvie E Kandel; Jed N Lampe
Journal:  Chem Res Toxicol       Date:  2014-08-29       Impact factor: 3.739

7.  Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.

Authors:  Alan L Myers; Yan-Ping Zhang; Jitesh D Kawedia; Ximin Zhou; Stacey M Sobocinski; Michael J Metcalfe; Mark A Kramer; Colin P N Dinney; Ashish M Kamat
Journal:  Drugs R D       Date:  2017-06

Review 8.  Contributions of DNA interstrand cross-links to aging of cells and organisms.

Authors:  Johannes Grillari; Hermann Katinger; Regina Voglauer
Journal:  Nucleic Acids Res       Date:  2007-12-14       Impact factor: 16.971

9.  The small 6C RNA of Corynebacterium glutamicum is involved in the SOS response.

Authors:  Jennifer Pahlke; Hana Dostálová; Jiří Holátko; Ursula Degner; Michael Bott; Miroslav Pátek; Tino Polen
Journal:  RNA Biol       Date:  2016-06-30       Impact factor: 4.652

10.  Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma.

Authors:  Caroline V M Verhagen; David M Vossen; Kerstin Borgmann; Floor Hageman; Reidar Grénman; Manon Verwijs-Janssen; Lisanne Mout; Roel J C Kluin; Marja Nieuwland; Tesa M Severson; Arno Velds; Ron Kerkhoven; Mark J O'Connor; Martijn van der Heijden; Marie-Louise van Velthuysen; Marcel Verheij; Volkert B Wreesmann; Lodewyk F A Wessels; Michiel W M van den Brekel; Conchita Vens
Journal:  Oncotarget       Date:  2018-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.